European Parliament - EPRS Science and Technology podcasts

The rapid growth of genetic databases worldwide, coupled with fast-decreasing costs and increased technological speed, has raised the possibility of every human genome on Earth being sequenced within this century. This brings to the forefront ethical and legal questions on data privacy and ownership. While a world genomic database would revolutionise preventive medicine and research, new forms of surveillance, discrimination and power imbalances could emerge...

Rising sea levels place coastal cities under constant threat. An estimated 250 million people currently live on land below projected annual flood levels, often in coastal cities such as London, Lagos, Mumbai or Shanghai; and this number may rise to 630 million by the end of the century. An additional 318 million people have been displaced since 2018, due to climate disasters...

'Innovation' is often used as a shorthand for improved technical, economic and social processes. However, any specific innovation involves the redistribution of costs and benefits, creating winners and losers. For some, regulation of technology should be avoided in case it hinders innovation, while, for others, regulation is an essential measure to mitigate risks. However, regulation and innovation are not a zero-sum game...

Managing the risks of the Covid-19 pandemic remains a challenge. While EU vaccination rates have reached three quarters of the population, new SARS-CoV-2 variants keep emerging in the EU. Although these variants appear to be generally less severe, they still pose challenges to health systems. The implementation of a globally effective vaccine strategy remains key to enhancing Europe's resilience...

Automated decision-making by systems that use machine learning to dynamically improve performance are still seen as lacking the 'human perspective' and flexibility to adapt to the particular nuances of specific cases. But perhaps, as they lack the 'cunning' to hide their biases, automated systems actually make fairer decisions than do humans, when these decisions are based on data that have been properly curated.

While killing all microorganisms in our bodies may seem tempting to some germaphobes, scientific evidence indicates that beneficial microorganisms (that live in nearly ubiquitous communities called microbiota) are an essential component of human health, and could form a new frontier for personalised medicine to fight non-communicable diseases and improve human health...

Following the first successful organ transplant in 1954, this procedure has become increasingly prevalent as it has revolutionised the treatment of end-stage organ failure. Nevertheless, organ shortage remains a critical problem which could potentially be overcome with xenotransplantation, regarded a promising alternative approach. In this podcast, we'll talk about the transplantation of animal derived organs and cells into humans...

The European Union has an ambitious climate strategy and is looking for ways to boost technologies that will make it possible. Could hydrogen and the deployment of related technology and infrastructure become a decisive factor in decarbonising specific industry sectors? In this podcast, we'll talk about hydrogen and its potential to accelerate the decarbonisation of European industry.

The way most food is produced is harming the planet. A profound change is needed, involving all agri-food actors. As consumers, we sit at the end of the agri-food chain. Our daily dietary choices implicitly support certain food systems, production methods and types of food. What could help us make better choices? In this podcast, we'll talk about ecolabels and their potential to nudge us towards more sustainable food choices.

Nanoparticles lie at the heart of a new method for delivering medicines inside the body – and they were crucial to the success of the Covid-19 mRNA vaccines. This new drug delivery method and others could transform the way we treat disease, potentially boosting the treatment of Alzheimer's, Parkinson's and HIV, among others. Insulin and Covid-19 vaccines might even become available as pills...